Search
Now showing items 1-10 of 10
International Retrospective Chart Review of Treatment Patterns in Severe Familial Mediterranean Fever, Tumor Necrosis Factor Receptor-Associated Periodic Syndrome, and Mevalonate Kinase Deficiency/Hyperimmunoglobulinemia D Syndrome
(Wiley, 2017)
Objective. Periodic fever syndrome (PFS) conditions are characterized by recurrent attacks of fever and localized inflammation. This study examined the diagnostic pathway and treatments at tertiary centers for familial ...
Classification Criteria For Autoinflammatory Recurrent Fevers
(2019)
Background Different diagnostic and classification criteria are available for hereditary recurrent fevers (HRF)-familial Mediterranean fever (FMF), tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), ...
Canakinumab For the Treatment of Autoinflammatory Recurrent Fever Syndromes
(Massachusetts Medical Soc, 2018)
BACKGROUND Familial Mediterranean fever, mevalonate kinase deficiency (also known as the hyper-immunoglobulinemia D syndrome), and the tumor necrosis factor receptor-associated periodic syndrome (TRAPS) are monogenic ...
Development Of The Autoinflammatory Disease Damage Index (Addi)
(BMJ, 2017)
Objectives Autoinflammatory diseases cause systemic inflammation that can result in damage to multiple organs. A validated instrument is essential to quantify damage in individual patients and to compare disease outcomes ...
A Preliminary Score for The Assessment of Disease Activity in Hereditary Recurrent Fevers: Results From The Aidai (Auto-Inflammatory Diseases Activity Index) Consensus Conference
(BMJ, 2011)
Background The systemic autoinflammatory disorders (SAID) share many clinical manifestations, albeit with variable patterns, intensity and frequency. A common definition of disease activity would be rational and useful in ...
Evidence-Based Recommendations For Genetic Diagnosis Of Familial Mediterranean Fever
(BMJ, 2015)
Familial Mediterranean fever (FMF) is a disease of early onset which can lead to significant morbidity. In 2012, Single Hub and Access point for pediatric Rheumatology in Europe (SHARE) was launched with the aim of optimising ...
